Virginia Tech® home

Saadman Ahmad

Biochemistry Ph.D. Student
  • Research area(s): Peptidoglycan structure in Borrelia Burgdorferi
Saadman Ahmad
Steger Hall, Cubicle 211-3A

Education

Ph.D., Biochemistry, Virginia Tech, 2025 Expected

M.S., Biochemistry, California State University Northridge, 2020

B.S., Biochemistry, University of Hong Kong, 2015

Experience

August 2022- Graduate Research Assistant, Biochemistry, Virginia Tech

July 2014-April 2015, Undergraduate researcher, Biochemistry, University of Hong Kong

June 2014-July 2014, Intern, Lab Medicine, Apollo Hospitals Dhaka

Associated Students Student Travel and Academic Research (STAR) Award, California State University Northridge, 2019

Graduate Studies Travel Award, California State University Northridge, 2019

  • Teaching Assistant for BCHM 3114 Biochemistry for Biotechnology and Life Sciences, Spring 2021
  • Teaching Assistant for BCHM 2024 Concepts of Biochemistry, Spring 2022

In the Jutras Lab, we focus on a causative agent of Lyme disease, Borrelia burgdorferi. I am specifically interested in the biosynthesis and structure of the unusual peptidoglycan of this bacterium as well as the enzymes involved in its remodeling.

As an undergraduate, I worked under Dr. Daisy Shum at the University of Hong Kong. I synthesized chitosan microspheres onto which I affixed chondroitinase ABC. I used this to degrade chondroitin sulphate proteoglycans that exist at the boundary of astrocytes and Schwann cells.

For my Master’s, I worked under Dr. Daniel Tamae. Our focus on the metabolism of glycolytic cancers; specifically, how we could leverage it to selectively target glycolytic cancers. I studied alternative detoxification pathways that are employed to detoxify reactive carbonyl species that arise as a result of glycolytic activity.

  • Ahmad, S., Cordova, B., Gardon, N., Bueno, L., Cambronero, E., Tamae, D. (2018) Inhibition of the Glyoxalase Pathway using S-p-Bromobenzyl Glutathion Cyclopentyl Diester (BBGC) Results in Reduced Cellular Metabolism in Cancer Cells. CSUPERB. Santa Clara, CA.
  • Cordova, B., Ahmad, S., Gardon, N., Shuck, S., Reque, L., Chan, L., Matavousian, A., Mason, J., Kenney, S., Anderson, J., Soetyono, L., Termini, J., and Tamae, D. (2019) Investigating the metabolic and biological effects of Glyoxalase 1 inhibition and knockdown in cancer cell lines. ACS National Meeting and Expo. San Diego, CA.
  • Ahmad, S., Reque, L., and Tamae, D. (2020) Aldo-keto reductases may be a compensatory detoxification pathway in response to Glyoxalase 1 inhibition in cancer cells. CSUPERB. Santa Clara, CA.